Bowel Cancer Immunotherapy Trial Shows Zero Relapses at Nearly Three Years
April 27, 2026
Bowel cancer immunotherapy trial shows no relapses, with NEOPRISM-CRC results at the American Association for Cancer Research.
Bowel cancer immunotherapy trial shows no relapses, with NEOPRISM-CRC results at the American Association for Cancer Research.
Gene therapy restores hearing in patients with rare genetic deafness, with dfnb9 trial results showing long-term benefits up to 2.5 years.
Anemia in older adults tied to higher dementia risk, with blood biomarkers linked to Alzheimer’s disease signaling neurodegeneration.
Covid-19 BA.3.2 Cicada variant shows 50+ spike protein mutations but remains low spread, offering insight into evolving Covid-19 dynamics
Blood test predicts alzheimer’s years early using plasma phosphorylated tau 217, with breakthrough findings from Mass General Brigham.